• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌中c-erbB-2癌蛋白的过表达:免疫组织学评估与基因扩增相关。

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.

作者信息

Venter D J, Tuzi N L, Kumar S, Gullick W J

出版信息

Lancet. 1987 Jul 11;2(8550):69-72. doi: 10.1016/s0140-6736(87)92736-x.

DOI:10.1016/s0140-6736(87)92736-x
PMID:2885574
Abstract

Amplification of the human protooncogene c-erbB-2 was found in 12 of 36 human breast tumours and was associated with increased levels of expression of the c-erbB-2 protein, measured both by immunohistological staining and by western blotting. The use of immunohistological staining to detect the level of expression of the c-erbB-2 protein in human breast adenocarcinomas may be of value in predicting tumour behaviour.

摘要

在36例人类乳腺肿瘤中,有12例发现人类原癌基因c-erbB-2发生扩增,且通过免疫组织化学染色和蛋白质印迹法检测发现,其与c-erbB-2蛋白表达水平升高相关。利用免疫组织化学染色检测人类乳腺腺癌中c-erbB-2蛋白的表达水平,可能对预测肿瘤行为具有重要价值。

相似文献

1
Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.人乳腺癌中c-erbB-2癌蛋白的过表达:免疫组织学评估与基因扩增相关。
Lancet. 1987 Jul 11;2(8550):69-72. doi: 10.1016/s0140-6736(87)92736-x.
2
Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.人乳腺癌中neu/HER-2/c-erbB-2原癌基因的扩增及蛋白过表达:与17号染色体基因序列缺失、家族史及预后的关系。
Br J Cancer. 1990 Oct;62(4):585-90. doi: 10.1038/bjc.1990.334.
3
Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.人腺癌中c-erbB-2癌基因在体内的扩增
Lancet. 1986 Apr 5;1(8484):765-7. doi: 10.1016/s0140-6736(86)91782-4.
4
c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue.恶性及非恶性乳腺组织中c-erB-2癌蛋白的表达
Ir J Med Sci. 1989 Jun;158(6):137-40. doi: 10.1007/BF02943053.
5
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.c-erbB-2癌蛋白的表达:人类乳腺癌的一种预后指标。
Cancer Res. 1989 Apr 15;49(8):2087-90.
6
What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.乳腺癌有哪些新进展?癌症发展的分子视角以及癌基因c-erbB-2在预后和疾病中的作用。
Pathol Res Pract. 1993 Dec;189(10):1233-52. doi: 10.1016/S0344-0338(11)80853-8.
7
An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.一项关于原发性人类乳腺癌中c-myc和c-erbB-2表达的免疫组织化学和原位杂交研究。
J Pathol. 1989 Jun;158(2):97-105. doi: 10.1002/path.1711580204.
8
c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.
J Pathol. 1989 Oct;159(2):107-11. doi: 10.1002/path.1711590204.
9
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Cancer Res. 1988 Mar 1;48(5):1238-43.
10
Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.c-erbB-2原癌基因的遗传改变作为人类原发性乳腺肿瘤的预后标志物
Oncology. 1993 Nov-Dec;50(6):412-7. doi: 10.1159/000227221.

引用本文的文献

1
HER2-Low Breast Cancer: Current Landscape and Future Prospects.HER2低表达乳腺癌:现状与未来展望
Breast Cancer (Dove Med Press). 2023 Aug 14;15:605-616. doi: 10.2147/BCTT.S366122. eCollection 2023.
2
family fusions are recurrent and actionable oncogenic targets across cancer types.家族融合是多种癌症类型中反复出现且可作用的致癌靶点。
Front Oncol. 2023 Apr 24;13:1115405. doi: 10.3389/fonc.2023.1115405. eCollection 2023.
3
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.乳腺癌中HER2的缺失:生物学机制与技术陷阱
Cancer Drug Resist. 2022 Oct 20;5(4):971-980. doi: 10.20517/cdr.2022.55. eCollection 2022.
4
Evaluation of HER2/neu expression in different types of salivary gland tumors: a systematic review and meta-analysis.评估不同类型唾液腺肿瘤中 HER2/neu 的表达:系统评价和荟萃分析。
J Med Life. 2022 May;15(5):595-600. doi: 10.25122/jml-2021-0394.
5
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity.一种新型的基于曲妥珠单抗的大规模筛选鉴定的 HER2 靶向抗体 5G9 具有强大的协同抗肿瘤活性。
EBioMedicine. 2020 Oct;60:102996. doi: 10.1016/j.ebiom.2020.102996. Epub 2020 Sep 16.
6
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification.具有异质性 HER2 扩增的乳腺癌中的体细胞突变和拷贝数变异。
Mol Oncol. 2020 Apr;14(4):671-685. doi: 10.1002/1878-0261.12650. Epub 2020 Mar 5.
7
Cystathionine-γ-lyase expression is associated with mitochondrial respiration during sepsis-induced acute kidney injury in swine with atherosclerosis.在患有动脉粥样硬化的猪中,胱硫醚-γ-裂解酶的表达与脓毒症诱导的急性肾损伤期间的线粒体呼吸相关。
Intensive Care Med Exp. 2018 Oct 20;6(1):43. doi: 10.1186/s40635-018-0208-z.
8
Her2 655 polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.Her2 655 多态性及其与乳腺癌风险的关联:病例对照研究的更新荟萃分析。
Sci Rep. 2018 May 9;8(1):7427. doi: 10.1038/s41598-018-25769-y.
9
gene amplification in gastric adenocarcinoma and its relationship with clinical and pathological findings.胃腺癌中的基因扩增及其与临床和病理结果的关系。
J Gastrointest Oncol. 2017 Dec;8(6):1046-1050. doi: 10.21037/jgo.2017.10.11.
10
Multifractal-based nuclei segmentation in fish images.基于多重分形的鱼类图像细胞核分割
Biomed Microdevices. 2017 Sep;19(3):67. doi: 10.1007/s10544-017-0208-x.